Neoplasms, Hematologic Recruiting Phase 1 / 2 Trials for Fludarabine (DB01073)

Also known as: Hematologic Neoplasm / Hematologic Neoplasms

IndicationStatusPhase
DBCOND0056760 (Neoplasms, Hematologic)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03983850Optimizing PTCy Dose and TimingTreatment